Form 4 for NVAX NOVAVAX INC
Accepted 2024-05-15 00:00:00 ET · period of report 2024-05-14 · accession 0001104659-24-062148 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-15 | 2024-05-14 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $6.97 | +19.7K | 86.3K | +30% | +$137.0K |
| D | 2024-05-15 | 2024-05-14 | NVAX | Dubovsky Filip | Pres, R, D | S - Sale+OE | $13.90 | -47.3K | 39.0K | -55% | -$657.6K |
| D | 2024-05-15 | 2024-05-14 | NVAX | Dubovsky Filip | Pres, R, D | M - OptEx | $0.00 | -19.7K | 47.7K | -29% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-14 | M | A | 19,652 | $6.97 | 86,265 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-14 | S | D | 47,312 | $13.90 | 38,953 | D | — | — | (F1) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $13.86 to $14.00, inclusive. The Reporting Person undertakes to provide to Novavax, Inc. (the "Company"), any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-05-14 | M | D | 19,652 | $0.00 | 47,728 | D | $6.97 · — to 2033-03-07 | 19,652 Common Stock | (F2) Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the March 7, 2023 grant date, and the remaining seventy-five percent (75%) of the shares vested or will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date. |